as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.20%
Downside
2.29%
Upside
52 Week's Low
52 Week's High
35.19%
Downside
55.19%
Upside
Check Apellis Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.1B
EPS (TTM)
-0.3991
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-188.3M
Revenue (TTM)
754.6M
Profit Margin
-30.24%
Return On Equity TTM
906467200.00%
Compare market cap, revenue, PE, and other key metrics of Apellis Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $3.1B | -13.29% | NA | -30.24% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Apellis Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Apellis Pharmaceuticals Inc investment value today
Current value as on today
₹71,168
Returns
Returns from Apellis Pharmaceuticals Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 23 analysts
82.61%
Buy
17.39%
Hold
0.00%
Sell
Based on 23 analysts, 82.61% of analysts recommend a 'BUY' rating for Apellis Pharmaceuticals Inc. Average target price of $38.56
Get share price movements and forecasts by analysts on Apellis Pharmaceuticals Inc.
What analysts predicted
35.58%UPSIDE
Target Price
$38.56
Current Price
$24.84
Analyzed by
23 Analysts
Target
$38.56
Apellis Pharmaceuticals Inc target price $38.56, a slight upside of 35.58% compared to current price of $24.84. According to 23 analysts rating.
Search interest for Apellis Pharmaceuticals Inc Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -92.22M → -42.15M (in $), with an average increase of 118.8% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 166.79M → 178.49M (in $), with an average increase of 6.6% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 109.7%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 187.4%
Price Dip
In the last 7 days, APLS stock has moved down by -11.7%
Organisation | Apellis Pharmaceuticals Inc |
Headquarters | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
Industry | Distribution Services |
CEO | Dr. Cedric Francois M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Pascal Deschatelets Ph.D. | Co-Founder & Chief Scientific Officer |
Mr. James G. Chopas CPA | VP, Corporate Controller & Chief Accounting Officer |
Ms. Meredith Kaya | Senior Vice President, Investor Relations & Strategic Finance |
Prof. Peter Hillmen M.D., Ph.D. | Head of Hematology Engagement & Member of PNH Scientific Advisory Board |
Mr. Alec Machiels J.D., MBA | Co-Founder & Director |
Mr. Timothy E. Sullivan | CFO & Treasurer |
Mr. David O. Watson Esq., J.D. | General Counsel & Secretary |
Dr. Cedric Francois M.D., Ph.D. | Co-Founder, President, CEO & Director |
Dr. Caroline R. Baumal M.D. | Chief Medical Officer |
Ms. Kelley Boucher | Chief People Officer |
Apellis Pharmaceuticals Inc share price today is $24.84 as on at the close of the market. Apellis Pharmaceuticals Inc share today touched a day high of $25.41 and a low of $24.79.
Apellis Pharmaceuticals Inc share touched a 52 week high of $38.55 on and a 52 week low of $16.1 on . Apellis Pharmaceuticals Inc stock price today i.e. is closed at $24.84,which is 35.56% down from its 52 week high and 54.29% up from its 52 week low.
Apellis Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Apellis Pharmaceuticals Inc (APLS) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Apellis Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Apellis Pharmaceuticals Inc share’s latest price of $24.84 as on September 13, 2025 at 1:29 am IST, you will get 0.4026 shares of Apellis Pharmaceuticals Inc. Learn more about
fractional shares .
Apellis Pharmaceuticals Inc stock has given -13.29% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?